EPIOXA CROSS-LINKING

RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC · Glaukos Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EPIOXA CROSS-LINKING, covering 2025-10-17 to 2025-10-17. Get the full timeline:

Most recent: FDA Approved: EPIOXA CROSS-LINKING — Original Application (Glaukos Corporation)